Introducing the Protagonist as 'One of Many'—How to Depict Characters | New Work Production Notes #3

I have started writing the main text of my new fantasy work.In the previous article, I wrote about how to decide the rules of ...

Protagonist Therapeutics: The Opt-Out That Turned A Biotech Into A Royalty Compounder

Protagonist Therapeutics has evolved into a royalty-driven company with two FDA-approved drugs. Read why PTGX stock is a Buy.
newswire

Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update

ICOTYDE™ (icotrokinra) approved by FDA in March for moderate-to-severe plaque psoriasis, triggering a $50 million milestone payment; Protagonist receives tiered royalties of 6% to 10% and is eligible ...

Protagonist Therapeutics (PTGX) Upgraded to Strong Buy: Here's What You Should Know

Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the ...
Game Rant

7 Isekai Anime Where The Protagonist Is the Worst Character

Cathlyn is an anime writer with years of experience covering some of the biggest and most popular series of all time. She loves writing listicles, features, and query-based articles about all things ...
Yahoo Finance

Protagonist (PTGX) Swings To A Profit As Two Drugs Near Blockbuster Status

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...